Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-25 @ 4:35 PM
NCT ID:
NCT01341457
Group ID:
EG000
Title:
170 mg LY2603618 + Gemcitabine
Description:
Gemcitabine 1000 mg/m² administered IV on days 1, 8 and 15 of at least one 28-day cycle. 170 mg LY2603628 administered IV on days 2, 9 and 16 of at least one 28-day cycle.
Participants experiencing benefit may continue on the combination therapy until discontinuation criteria are met.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
7
Other Number Affected:
7
Other Number At Risk:
7
Study:
NCT01341457
Results Section:
NCT01341457
Adverse Events Module:
NCT01341457